SANDREA LAWLER: Open Payments
NPI 1932816394 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 29 payments from 8 companies in 2025. Trend: 2023 $778 · 2024 $713 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $233 |
| ABBVIE INC. | 13 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Alkermes, Inc. | 2 | $38 |
| Tris Pharma Inc | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: FANAPT, VRAYLAR, CAPLYTA, REXULTI, ARISTADA, Dyanavel XR, Qelbree.
Industry payments across AL — which companies pay providers there.
